Cancer is the most threatening disorder with increasing stuffers globally. Immune system of human body carries a set of defensive processes whenever cancer is detected by its specialized cells. While immunosurveillance, the host fight against foreign antigens. By targeting surface antigens expressed in tumor cells, monoclonal antibodies have demonstrated efficacy as cancer therapeutics. The checkpoint blockade therapy involves the use of antibodies to block pathways inhibiting the endogenous immune response to cancer. Adoptive cell transfer (ACT) is highly personalized cancer bearing host of immune cells with direct anticancer activity. We emphasize how the history of cancer immunotherapy paved the path for discoveries that are now standard of care in this review article.
Over the last few decades, we have observed several global outbreaks of severe respiratory infections. The current outbreak is novel severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). It is a rapidly spreading disease affecting millions of people worldwide as well as birds and mammals also. It predominantly caused respiratory tract and gastrointestinal tract symptoms and other mild to very severe clinical signs. Among the countries most affected by the disease are the United States of America (USA), India, Brazil, Russia and France with recording the highest infection, morbidity, and mortality rates. Since early January 2021 many articles have been published on COVID-19. Most of these articles were consistent with the reports on the mode of transmission, spread, duration, and severity of the sickness. This worldwide pandemic has put a challenge to identify the therapeutics for its prevention and treatment. Currently, there’s no specific treatment against the SARS-CoV-2 infection. Based on the different clinical phases and pathological features the various drugs are used to treat. The volume and the pace of the clinical trials launched to evaluate the safety and efficacy of numerous agents reflect the need for high-quality evidence for various therapies to be practiced by clinicians. Thus, this review comprehensively discusses the most critical aspects and overall treatments used for COVID 19, including ayurvedic treatments and vaccines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.